Understanding the importance of IkB-b as a selective co-activator of NF-kB signaling

了解 IkB-b 作为 NF-kB 信号传导选择性共激活剂的重要性

基本信息

  • 批准号:
    10404063
  • 负责人:
  • 金额:
    $ 40万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The transcription factors of the NF-kB family are central regulators of a wide variety of biological processes. This includes events as fundamental as embryonic development and cellular survival as well as the intricate responses of the innate and adaptive immune system. What has remained elusive are the mechanisms that allow this limited set of five proteins to orchestrate the radically different transcriptional programs which are required for these disparate cellular functions. Understanding the details of NF-kB-dependent transcription, however, is of paramount importance for efforts to achieve targeted therapeutic intervention in cases of pathological NF-kB activation, such as sepsis, rheumatoid arthritis and cancer. One of the factors that fine-tune NF-kB activation is the inhibitor of NF-kB, isoform b (IkB-b), which has been shown to serve an intriguing dual role as a conventional inhibitor, and atypical co-activator, of NF-kB- dependent transcription. In unstimulated cells, IkB-b sequesters NF-kB dimers in the cytoplasm and thus prevents transcriptional activation, whereas upon stimulation a nuclear form of IkB-b enhances transcription of a subset of NF-kB-dependent genes. Consequently, IkB-b-deficient macrophages produce starkly reduced levels of the cytokine TNF-a following exposure to an activating stimulus, whereas levels of the cytokine IL-6 are largely unaffected. The goal of this project is to comprehensively understand the role of IkB-b as a selective co-activator of NF-kB activation. This will be accomplished by rigorously characterizing the mechanism that underlies IkB-b function on a biochemical and molecular level. Furthermore, the full extent of IkB-b co-activator function and its effect on global transcription will be probed using cutting-edge genomics techniques, including RNA-seq and ChIP- seq. These data sets will then be integrated to create a holistic model of IkB-b function. Finally, the true physiological relevance of IkB-b will be determined in vivo with mouse models of acute and chronic inflammation, as well as bacterial infection.
项目总结/摘要 NF-κ B家族的转录因子是多种生物过程的中心调节因子。 这包括胚胎发育和细胞存活等基本事件, 先天性和适应性免疫系统的反应。仍然难以捉摸的是, 允许这五种蛋白质的有限集合来协调完全不同的转录程序, 这些不同的细胞功能所需要的。了解NF-κ B依赖性转录的细节, 然而,对于在以下情况下实现靶向治疗干预的努力至关重要: 病理性NF-κ B活化,如败血症、类风湿性关节炎和癌症。 微调NF-κ B活化的因素之一是NF-κ B的抑制剂,亚型B(IkB-B),其已被证实是NF-κ B的抑制剂。 显示出作为NF-kB的常规抑制剂和非典型共激活剂的有趣的双重作用, 依赖转录在未受刺激的细胞中,IkB-b在细胞质中螯合NF-kB二聚体,从而 阻止转录激活,而在刺激时,核形式的IkB-b增强转录, NF-kB依赖基因的子集。因此,IkB-b缺陷的巨噬细胞产生明显减少的 暴露于活化刺激后细胞因子TNF-α的水平,而细胞因子IL-6的水平 基本上不受影响。 本项目的目标是全面了解IkB-b作为NF-kB选择性共激活剂的作用 activation.这将通过严格表征IkB-b功能的基础机制来实现 在生物化学和分子水平上。此外,IkB-b共激活剂功能的完整程度及其作用 将使用尖端的基因组学技术,包括RNA-seq和ChIP, seq.然后将这些数据集整合以创建IkB-b功能的整体模型。最后,真正的 IkB-b的生理相关性将在体内用急性和慢性炎症的小鼠模型来确定。 炎症,以及细菌感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sankar Ghosh其他文献

Sankar Ghosh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sankar Ghosh', 18)}}的其他基金

Exploring the role of a novel autoimmune disease-associated lncRNA in Treg biology
探索一种新型自身免疫性疾病相关 lncRNA 在 Treg 生物学中的作用
  • 批准号:
    10598708
  • 财政年份:
    2022
  • 资助金额:
    $ 40万
  • 项目类别:
Exploring a novel lncRNA regulator of T-cell function
探索 T 细胞功能的新型 lncRNA 调节因子
  • 批准号:
    10427423
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Exploring a novel lncRNA regulator of T-cell function
探索 T 细胞功能的新型 lncRNA 调节因子
  • 批准号:
    10303748
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Understanding the importance of IkB-b as a selective co-activator of NF-kB signaling
了解 IkB-b 作为 NF-kB 信号传导选择性共激活剂的重要性
  • 批准号:
    10153691
  • 财政年份:
    2018
  • 资助金额:
    $ 40万
  • 项目类别:
miRNA-mediated regulation of LPS tolerance
miRNA 介导的 LPS 耐受性调节
  • 批准号:
    9058465
  • 财政年份:
    2015
  • 资助金额:
    $ 40万
  • 项目类别:
miRNA-mediated regulation of LPS tolerance
miRNA 介导的 LPS 耐受性调节
  • 批准号:
    8987945
  • 财政年份:
    2015
  • 资助金额:
    $ 40万
  • 项目类别:
Understanding the pathway that links lipopolysaccharide (LPS) to mitochondrial function using a novel mouse model
使用新型小鼠模型了解连接脂多糖 (LPS) 与线粒体功能的途径
  • 批准号:
    9068921
  • 财政年份:
    2015
  • 资助金额:
    $ 40万
  • 项目类别:
Understanding the Role of a Long Noncoding RNA in Celiac Disease
了解长非编码 RNA 在乳糜泻中的作用
  • 批准号:
    8839530
  • 财政年份:
    2014
  • 资助金额:
    $ 40万
  • 项目类别:
Understanding the Role of a Long Noncoding RNA in Celiac Disease
了解长非编码 RNA 在乳糜泻中的作用
  • 批准号:
    9336894
  • 财政年份:
    2014
  • 资助金额:
    $ 40万
  • 项目类别:
Understanding the Role of a Long Noncoding RNA in Celiac Disease
了解长非编码 RNA 在乳糜泻中的作用
  • 批准号:
    9115578
  • 财政年份:
    2014
  • 资助金额:
    $ 40万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了